Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Oct 1, 2019 (7 years ago)

Motion Sickness Strips

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Subpotent Drug

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Motion Sickness Strips (meclizine hydrochloride) 25 mg strips, 8-count box, Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501, NDC 69842-288-01. UPC 5042849946

Affected NDC 69842-0288-01

Compare with the code on your package — it is the most precise check available.

Drug: Meclizine

Recalling firm
Sato Pharmaceutical Inc.
NDC code
69842-288-01
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0325-2020 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Meclizine recalls

See all
Class I · High risk

Meclizine Hydrochloride Tablets USP

Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride

Terminated Labeling / mix-up Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-122-06 D-0767-2022

Other recalls by Sato Pharmaceutical Inc.

All 2019 recalls